Trevi Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 911,498 | 1.29% |
Hedge Funds | 9,964,123 | 14.1% |
General Public | 14,479,771 | 20.6% |
VC/PE Firms | 18,751,466 | 26.6% |
Institutions | 26,328,235 | 37.4% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 17.3%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
11,370,376 | US$36.0m | 0% | 2.02% | |||
7,381,090 | US$23.4m | 0% | 0.96% | |||
5,564,123 | US$17.6m | -2.12% | 0.31% | |||
4,400,000 | US$13.9m | 0% | 0.05% | |||
3,422,675 | US$10.8m | 0.01% | 0.43% | |||
3,147,200 | US$10.0m | 0% | 0.26% | |||
2,645,000 | US$8.4m | 4.34% | 1.67% | |||
2,375,709 | US$7.5m | 2.41% | no data | |||
2,303,648 | US$7.3m | 2.69% | no data | |||
2,200,000 | US$7.0m | 0% | 0.74% | |||
1,391,577 | US$4.4m | 50.3% | 2.74% | |||
1,340,960 | US$4.3m | 0% | 0.62% | |||
1,131,821 | US$3.6m | -11.5% | 0.03% | |||
897,965 | US$2.8m | 5.66% | no data | |||
844,235 | US$2.7m | -2.27% | 0.7% | |||
798,249 | US$2.5m | 7.7% | no data | |||
740,128 | US$2.3m | -18.7% | 0.2% | |||
506,082 | US$1.6m | -60.8% | 0.96% | |||
352,489 | US$1.1m | 0% | no data | |||
327,692 | US$1.0m | 4.3% | no data | |||
214,433 | US$679.8k | 4.78% | no data | |||
213,313 | US$676.2k | 0.9% | no data | |||
200,000 | US$634.0k | 0% | 0.05% | |||
137,873 | US$437.0k | 0% | 0.02% | |||
128,627 | US$407.8k | -3.56% | no data |